| SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity L Zhang, CB Jackson, H Mou, A Ojha, H Peng, BD Quinlan, ... Nature communications 11 (1), 6013, 2020 | 1000 | 2020 |
| Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis BA Johnson, X Xie, AL Bailey, B Kalveram, KG Lokugamage, A Muruato, ... Nature 591 (7849), 293-299, 2021 | 611 | 2021 |
| Rapid generation of neutralizing antibody responses in COVID-19 patients MS Suthar, MG Zimmerman, RC Kauffman, G Mantus, SL Linderman, ... Cell Reports Medicine 1 (3), 2020 | 541 | 2020 |
| Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures A Vanderheiden, P Ralfs, T Chirkova, AA Upadhyay, MG Zimmerman, ... Journal of virology 94 (19), 10.1128/jvi. 00985-20, 2020 | 291 | 2020 |
| Development of a rapid focus reduction neutralization test assay for measuring SARS‐CoV‐2 neutralizing antibodies A Vanderheiden, VV Edara, K Floyd, RC Kauffman, G Mantus, ... Current protocols in immunology 131 (1), e116, 2020 | 109 | 2020 |
| Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects MF Jennewein, AJ MacCamy, NR Akins, J Feng, LJ Homad, NK Hurlburt, ... Cell reports 36 (2), 2021 | 99 | 2021 |
| COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis AL Soung, A Vanderheiden, AS Nordvig, CA Sissoko, P Canoll, ... Brain 145 (12), 4193-4201, 2022 | 82 | 2022 |
| Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge A Muruato, MN Vu, BA Johnson, ME Davis-Gardner, A Vanderheiden, ... PLoS biology 19 (11), e3001284, 2021 | 60 | 2021 |
| Neuroinflammation and COVID-19 A Vanderheiden, RS Klein Current opinion in neurobiology 76, 102608, 2022 | 54 | 2022 |
| SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun 11: 6013 L Zhang, CB Jackson, H Mou, A Ojha, H Peng, BD Quinlan, ... | 49 | 2020 |
| CCR2 signaling restricts SARS-CoV-2 infection A Vanderheiden, J Thomas, AL Soung, ME Davis-Gardner, K Floyd, F Jin, ... MBio 12 (6), e02749-21, 2021 | 40 | 2021 |
| Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice L Grigoryan, A Lee, AC Walls, L Lai, B Franco, PS Arunachalam, Y Feng, ... npj Vaccines 7 (1), 55, 2022 | 30 | 2022 |
| Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection L Cervantes-Barragan, A Vanderheiden, CJ Royer, ME Davis-Gardner, ... bioRxiv, 2021.05. 12.443948, 2021 | 11 | 2021 |
| CD8+ T cell intrinsic MAVS promotes antigen-specific responses and mitochondrial metabolism during West Nile Virus neuroinvasive disease A Vanderheiden, R Aguilar-Valenzuela, H Verkerke, M Price, JM Boss, ... The Journal of Immunology 204 (1_Supplement), 94.1-94.1, 2020 | 2 | 2020 |
| Rapid generation of neutralizing antibody responses in COVID-19 patients (preprint) MS Suthar, M Zimmerman, R Kauffman, G Mantus, S Linderman, ... | 2 | 2020 |
| Mouse Adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge (preprint) A Muruato, M Vu, BA Johnson, M Davis-Gardner, AR Vanderheiden, ... | 1 | 2021 |
| CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment (preprint) M Kar, KEE Johnson, A Vanderheiden, EJ Elrod, K Floyd, E Geerling, ... | | 2024 |
| CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment M Kar, KEE Johnson, A Vanderheiden, EJ Elrod, K Floyd, E Geerling, ... bioRxiv, 2024.01. 23.576505, 2024 | | 2024 |
| Vaccination prevents IL-1β-mediated cognitive deficits after COVID-19 A Vanderheiden, J Hill, X Jiang, B Deppen, G Bamunuarachchi, ... Research Square, 2023 | | 2023 |
| A wild boar cathelicidin peptide derivative inhibits severe acute respiratory syndrome coronavirus-2 and its drifted variants T von Beck, K Navarrete, NA Arce, M Gao, GA Dale, ME Davis-Gardner, ... Scientific Reports 13 (1), 14650, 2023 | | 2023 |
